SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001818382-24-000132
Filing Date
2024-06-17
Accepted
2024-06-17 16:11:02
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718655055.html 4  
1 FORM 4 wk-form4_1718655055.xml 4 3871
  Complete submission text file 0001818382-24-000132.txt   5416
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1001 PINEHURST DRIVE CHAPEL HILL NC 27517
Business Address
Bamforth John Philip (Reporting) CIK: 0002026341 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 241048319